Alexion Pharmaceuticals Inc (ALXN)

ALXN (NASDAQ:Drugs) EQUITY
$125.77
neg -0.30
-0.24%
Today's Range: 124.88 - 126.99 | ALXN Avg Daily Volume: 3,089,300
Last Update: 06/26/17 - 1:16 PM EDT
Volume: 1,174,315
YTD Performance: 3.04%
Open: $126.59
Previous Close: $126.07
52 Week Range: $110.56 - $205.29
Oustanding Shares: 224,556,542
Market Cap: 28,345,772,297
6-Month Chart
TheStreet Ratings Grade for ALXN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 11 12 12
Moderate Buy 2 1 1 1
Hold 4 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.63 1.72 1.68 1.68
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 60.11
Price Earnings Comparisons:
ALXN Sector Avg. S&P 500
60.11 60.40 30.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
4.83% 2.02% -22.02%
GROWTH 12 Mo 3 Yr CAGR
Revenue 18.40 1.00 0.25
Net Income 176.30 0.60 0.16
EPS 162.70 0.40 0.11
Earnings for ALXN:
EBITDA 1.19B
Revenue 3.08B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $1.08 $1.16 $4.54 $5.49
Number of Analysts 8 1 8 1
High Estimate $1.11 $1.16 $4.77 $5.49
Low Estimate $1.05 $1.16 $4.44 $5.49
Prior Year $0.93 $1.18 $3.78 $4.54
Growth Rate (Year over Year) 16.13% -1.69% 20.01% 21.03%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Carolyn Boroden

 | Jun 19, 2017 | 7:00 AM EDT
I am starting to watch a couple of key price zones on the way down.
RMPIA
By

Jim Cramer

 | Jun 15, 2017 | 7:31 AM EDT
We forget that a big hedge fund or mutual fund switching out of tech winners into everything else can roil the market.
RMPIA
By

James "Rev Shark" DePorre

 | Jun 1, 2017 | 11:12 AM EDT
But I don't have a lot of confidence in this market beyond the intraday action.
By

Carolyn Boroden

 | May 30, 2017 | 1:00 PM EDT
Alexion Pharmaceuticals presents a tradeable countertrend opportunity.
RMPIA
By

Doug Kass

 | May 24, 2017 | 3:18 PM EDT
"If you work for a living, why do you kill yourself working?" -- Tuco,
By

Bob Byrne

 | May 24, 2017 | 7:00 AM EDT
If you want to stay active, you'll have to do more homework.
RMPIA
By

Doug Kass

 | May 23, 2017 | 3:44 PM EDT
"There are two kinds of spurs, my friend. Those that come in by the door; those that come in by the window.." -- Tuco, "
RMPIA
By

Bret Jensen

 | Apr 27, 2017 | 8:49 AM EDT
It is hard to keep up with the flurry of first-quarter earnings reports hitting the wires this morning. Here are a few that caught my eye today.
RMPIA
By

Guy Ortmann

 | Jan 9, 2017 | 1:33 PM EST
These companies show signs of a change of direction.
RMPIA
By

Jim Cramer

 | Jan 3, 2017 | 2:09 PM EST
Even among the losers, buys are scarce.
Under Armour's founder Kevin Plank has never been one to sound weak in a public setting. P...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.